The impact of the pandemic and the COVID-19 vaccine hesitancy on people living with HIV: a single-center cross-sectional study in Caracas, Venezuela

Author:

Forero-Peña David A.1,Carrión-Nessi Fhabián S.2,Forero-Peña José L.3,Camejo-Ávila Natasha A.3,Mendoza-Millán Daniela L.2,Omaña-Ávila Óscar D.2,Maricuto Andrea L.1,Velásquez Viledy L.1,Mejía-Bernard Mario D.2,Rodriguez-Saavedra Carlis M.3,Marcano-Rojas María V.3,Contreras Yoesmir2,Guerra Luis J.1,Alvarado María F.1,Carballo Martín1,Caldera Jocays1,Guevara Rafael N.1,Redondo María C.1,Landaeta María E.1

Affiliation:

1. University Hospital of Caracas

2. Central University of Venezuela

3. Biomedical Research and Therapeutic Vaccines Institute

Abstract

Abstract Background The COVID-19 pandemic has disrupted multiple health services, including HIV testing, care, and treatment services, jeopardizing the achievement of the UNAIDS 90-90-90 global target. While there are limited studies assessing the impact of the COVID-19 pandemic on people living with HIV (PLHIV) in Latin America, there are none, to our knowledge, in Venezuela. This study aims to assess the impact of the pandemic and COVID-19 vaccine hesitancy among PLHIV seen at the outpatient clinic of a reference hospital in Venezuela. Methods We conducted a cross-sectional study among PLHIV aged 18 years and over seen at the Infectious Diseases Department of the University Hospital of Caracas, Venezuela between March 2021 and February 2022. Results A total of 238 PLHIV were included in the study. The median age was 43 years (IQR 24), and the majority were male (68.9%). Most patients (88.2%; n = 210) came for routine check-ups, while 28 (11.3%) were newly diagnosed. The majority of patients (96.1%) were on antiretroviral therapy (ART), but only 67.8% had a viral load test, with almost all (95.6%) being undetectable. Among those who attended regular appointments, 11.9% reported missing at least one medical consultation, and 3.3% reported an interruption in their ART refill. More than half of the patients (55.5%) had received at least one dose of the COVID-19 vaccine, while the rest expressed hesitancy to get vaccinated. Most patients with COVID-19 vaccine hesitancy were male (65.1%), younger than 44 years (57.5%), employed (47.2%), and had been diagnosed with HIV for less than one year (33%). However, no statistically significant differences were found between vaccinated patients and those with COVID-19 vaccine hesitancy. Age was a risk factor for missing consultations, while not having an alcoholic habit was identified as a protective factor against missing consultations. Conclusion This study found that the pandemic had a limited impact on adherence to medical consultations and interruptions in ART. However, it documented a high rate of COVID-19 vaccine hesitancy among PLHIV seen at the University Hospital of Caracas.

Publisher

Research Square Platform LLC

Reference77 articles.

1. Global HIV. & AIDS statistics — 2021 Fact sheet [https://www.unaids.org/en/resources/fact-sheet].

2. Global HIV. & AIDS statistics — 2020 fact sheet [https://www.unaids.org/en/resources/fact-sheet].

3. MPPS OO., ONUSIDA: Tratamiento antirretroviral para personas con VIH - Guía práctica: Venezuela. In. Caracas: Ministerio del Poder Popular para la Salud de Venezuela; 2021.

4. Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens;Inzaule SC;Lancet Infect Dis,2019

5. Venezuela's public health crisis: a regional emergency;Page KR;Lancet,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3